D-1727-2019 Class II Terminated

Recalled by US Pharmaceuticals Inc. — Belleville, NJ

FDA drug recall D-1727-2019 was initiated by US Pharmaceuticals Inc. on July 11, 2019 and is designated Class II. Reason for recall: CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process. The recall status is terminated (terminated June 25, 2020). Affected quantity: 76 cases.

Recall Details

Product Type
Drugs
Report Date
August 21, 2019
Initiation Date
July 11, 2019
Termination Date
June 25, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
76 cases

Product Description

Children Glycerin Suppositories Laxative for ages 2 to 5. Package Size 25-count.Distributed by Walgreen CO. 200 Wilmot Rd. Deerfield IL 60015. NDC#0363-0440-25,

Reason for Recall

CGMP Deviations: Out of Specification results for either total microbial count or total organic carbon in the purified water utilized in the manufacturing process.

Distribution Pattern

Distributed Nationwide in the USA

Code Information

Lot #88J17 EXP 07/2019